119 related articles for article (PubMed ID: 2618078)
1. Biological fate of sirdalud in animals and man.
Koch P; Hirst DR; von Wartburg BR
Xenobiotica; 1989 Nov; 19(11):1255-65. PubMed ID: 2618078
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of orally administered tizanidine in healthy volunteers.
Tse FL; Jaffe JM; Bhuta S
Fundam Clin Pharmacol; 1987; 1(6):479-88. PubMed ID: 3447935
[TBL] [Abstract][Full Text] [Related]
3. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J
Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels, biotransformation and excretion of oxatomide (R 35 443) in rats, dogs and man.
Meuldermans W; Hendrickx J; Knaeps F; Lauwers W; Heykants J; Grindel JM
Xenobiotica; 1984 Jun; 14(6):445-62. PubMed ID: 6475104
[TBL] [Abstract][Full Text] [Related]
5. [The use of sirdalud in painful muscle tonic syndromes].
Damulin IV
Ter Arkh; 1997; 69(10):68-72. PubMed ID: 9471796
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and metabolism of 14C-labelled alinidine in man and dogs.
Arndts D; Leb G; Förster HJ
Eur J Drug Metab Pharmacokinet; 1981; 6(3):225-36. PubMed ID: 7308242
[TBL] [Abstract][Full Text] [Related]
7. [The use of sirdalud in cerebral palsy in children].
Brin IL; Kurenkov AL; Gotlib VIa
Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(10):30-3. PubMed ID: 10536809
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of xilobam in laboratory animals and man.
Wu WN; Hills JF; Egan RS
Xenobiotica; 1994 Jul; 24(7):649-62. PubMed ID: 7975729
[TBL] [Abstract][Full Text] [Related]
9. [Sirdalud in the practice of the pediatric neurologist].
Shumilina AP; Guzeva VI; Skoromets AA
Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(10):45-6. PubMed ID: 9424348
[No Abstract] [Full Text] [Related]
10. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
[TBL] [Abstract][Full Text] [Related]
11. Excretion and metabolism of lorcainide in rats, dogs and man.
Meuldermans W; Hurkmans R; Swysen E; Hendrickx J; Thijssen J; Lauwers W; Heykants J
Eur J Drug Metab Pharmacokinet; 1983; 8(4):335-49. PubMed ID: 6673971
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
13. Comparative metabolic disposition of oral doses of omeprazole in the dog, rat, and mouse.
Hoffmann KJ; Renberg L; Olovson SG
Drug Metab Dispos; 1986; 14(3):336-40. PubMed ID: 2872035
[TBL] [Abstract][Full Text] [Related]
14. The influence of metabolic degradation on the blood pressure lowering effect of clonidine in rabbits after different routes of administration.
Hoefke W; Darda S; Gaida W
Arzneimittelforschung; 1985; 35(1A):401-5. PubMed ID: 4039177
[TBL] [Abstract][Full Text] [Related]
15. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and metabolism of HOE 077. Preclinical studies.
Kellner HM; Volz M; Badder E; Kürzel GU; Eckert HG
J Hepatol; 1991; 13 Suppl 3():S48-61; discussion S62. PubMed ID: 1667669
[TBL] [Abstract][Full Text] [Related]
17. Excretion and biotransformation of cisapride in dogs and humans after oral administration.
Meuldermans W; Van Peer A; Hendrickx J; Lauwers W; Swysen E; Bockx M; Woestenborghs R; Heykants J
Drug Metab Dispos; 1988; 16(3):403-9. PubMed ID: 2900732
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
Mukai H; Sugimoto T; Ago M; Morino A
Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
[TBL] [Abstract][Full Text] [Related]
20. On the pharmacokinetics of domperidone in animals and man III. Comparative study on the excretion and metabolism of domperidone in rats, dogs and man.
Meuldermans W; Hurkmans R; Swysen E; Hendrickx J; Michiels M; Lauwers W; Heykants J
Eur J Drug Metab Pharmacokinet; 1981; 6(1):49-60. PubMed ID: 6788556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
